Assyro AI

FDA Orange Book · active-ingredient family

Protriptyline hydrochloride

Protriptyline hydrochloride is approved as 1 brand and 5 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:VIVACTIL · NDA 016012

1

Brand (NDA)

5

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · tablet

ProductApplicantApplicationTEApproved
VIVACTIL×2TEVA WOMENSNDA 016012Approved Prior to Jan 1, 1982

Generic (ANDA) products (5)

ProductApplicantApplicationTEApproved
PROTRIPTYLINE HYDROCHLORIDE×2EPIC PHARMA LLCANDA 202220ABNov 19, 2012
PROTRIPTYLINE HYDROCHLORIDE×2SIGMAPHARM LABS LLCANDA 090462ABMay 03, 2010
PROTRIPTYLINE HYDROCHLORIDE×2HIKMAANDA 078913Sep 16, 2008
VIVACTILCHARTWELL RXANDA 073644Aug 24, 1995
VIVACTILCHARTWELL RXANDA 073645Aug 24, 1995

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Protriptyline hydrochloride — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.